Showing results (821-830 of 896) with videos related to

Sort By:
Pageof 90
Circulation. Heart Failure|March 2, 2026
MUTTON-HF: Rationale and Design of a Study of an Indigenous Food is Medicine InterventionLauren A Eberly, Carmen George, Sharon Sandman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 26, 2026
Clinical outcomes of stereotactic MRI-guided adaptive radiotherapy for renal tumors in patients with a solitary kidneyClaire van Vliet, Joyce Caro, Omar Bohoudi, et al.
The Journal of Experimental Medicine|March 26, 2026
Basophils drive the resolution and promote wound healing in adult and aged miceJulie Bex, Victoria Peter, Chaimae Saji, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2014
[Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency]R Bahi, G Pignot, Y Hammoudi, et al.
The Journal of Experimental Medicine|March 28, 2012
Transglutaminase is essential for IgA nephropathy development acting through IgA receptorsLaureline Berthelot, Christina Papista, Thiago T Maciel, et al.
JAMA Internal Medicine|July 27, 2026
An Indigenous Food Is Medicine Intervention: The MUTTON-HF Randomized Clinical TrialLauren A Eberly, Carmen George, Sharon Sandman, et al.
JAMA Oncology|December 14, 2018
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical TrialAxel Bex, Peter Mulders, Michael Jewett, et al.
European Urology|June 23, 2019
Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME)Roderick Emile De Bruijn, Peter Mulders, Michael A Jewett, et al.
The Oncologist|March 14, 2023
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19Cristiane Decat Bergerot, Jasnoor Malhotra, Paulo Bergerot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup TrialTim Eisen, Eleni Frangou, Bhavna Oza, et al.
Pageof 90